Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Troutman Sanders LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
EPA Finalizes Hazardous Waste Pharmaceuticals Rule
Today U.S. EPA finalized new hazardous waste regulations in its final Management Standards for Hazardous Waste Pharmaceuticals rule.
United States
17 Dec 2018
2
NY AG Announces Settlement With Health App Developers Over Marketing And Privacy Practices
On March 23, New York Attorney General Eric Schneiderman announced settlements with three health-related applications sold in Apple's App Store and Google's Play Store.
United States
4 Apr 2017
3
FDA's Postmarket Management Of Cybersecurity In Medical Devices
By its terms, the Guidance applies to: "1) medical devices that contain software (including firmware) or programmable logic, and 2) software that is a medical device, including mobile medical applications."
United States
14 Feb 2017
4
Methods For Detecting Naturally Occurring Cell-Free Fetal DNA Are Not Patent Eligible Under §101
Ariosa Diagnostics, Inc. v. Sequenom, Inc., No. 2014-1139, -1144, 2015 U.S. App. LEXIS 9855 (Fed. Cir. Jun. 15, 2015) (Reyna, J.) (Linn, J., concurring).
United States
23 Jun 2015
5
The DOJ’s Generic Drug Antitrust Investigation May Be Just Beginning
Late last month, generic pharmaceutical companies in the United States received a signal that the Department of Justice's ("DOJ") Antitrust Division may be widening the scope of its federal investigation...
United States
22 Apr 2015
6
The Prescription for New .Pharmacy Top Level Domain Names
The .PHARMACY tld, operated by the National Association of Boards of Pharmacy, is now open for registration to certain types of businesses.
United States
18 Feb 2015
7
Supreme Court Applies "Clear Error" To Subsidiary Factual Findings In Federal Circuit’s De Novo Claim Construction
Teva Pharm. USA, Inc. v. Sandoz, Inc., No. 13-854, 2015 U.S. LEXIS 628 (Sup. Ct. Jan. 20, 2015) (Breyer, J.) (Thomas, J., dissenting)
United States
2 Feb 2015
8
Federal Circuit Affirms Patent Ineligibility Of Myriad BRCA Claims, Leaves Open Potential Patentability Of Methods To Screen For Newly Discovered Gene Mutations
The Federal Circuit invalidated six claims in three patents related to breast cancer susceptibility genes, BRCA1 and BRCA2, which produce tumor suppressing proteins.
United States
19 Jan 2015
9
United States
19 Jan 2015
10
FDA’s POCA Scoring System For New Drug Names
In spite of FDA’s best efforts, medication errors continue to burden our health care system.
United States
13 Jan 2015
11
Federal Circuit Review - Issue 37
Specific Claim Limitation That Uses "Comprising" in an Unpredictable Art May Not Be Enabled; and "Active Inducement" Under § 271(f)(1) Does Not Require a Third Party.
United States
6 Jan 2015
12
Federal Circuit Review - Issue 36
Lawsuit Seeking Declaratory Judgment to Shield Drug from Patent Is Premature When Brought Prior to Filing for FDA Approval
United States
23 Dec 2014
Links to Result pages
 
1